Director S/holding-Replacemnt

Dechra Pharmaceuticals PLC
22 May 2002


The issuer has made the following amendment to the Directors Shareholding
announcement released on Tuesday 21 May at 13:37 under RNS No 2097W.

Boxes 15 and 16 for 'Simon Evans' (Director) should read 15: 663,000 and not 
643,000 and 16: should read 1.32% and not 1.28% as previously stated. 

All other details remain unchanged.

The full corrected version is shown below.





                       DEALINGS BY DIRECTORS


1)  NAME OF COMPANY

    DECHRA PHARMACEUTICALS PLC

2)  NAME OF DIRECTOR

    MALCOLM DIAMOND

3)  Please state whether notification indicates that it is in respect of
    holding of the shareholder named in 2 above or in respect of a
    non-beneficial interest or in the case of an individual holder
    if it is a holding of that person's spouse or children under the
    age of 18 or in respect of an non-beneficial interest

     AS ABOVE

4)  Name of the registered holder(s) and, if more than one holder, the
    number of shares held by each of them. (If notified)

     AS ABOVE

5)  Please state whether notification relates to a person(s) connected
    with the Director named in 2 above and identify the connected person(s)

     AS ABOVE

6)  Please state the nature of the transaction. For PEP transactions
    please indicate whether general/single co PEP and if discretionary/non
    discretionary

     PURCHASE OF SHARES

7)  Number of shares/amount of
    stock acquired


       5,000

8)   (0.01%)
    of issued Class



9)  Number of shares/amount
    of stock disposed

      N/A

10)  ( N/A %)
    of issued Class



11) Class of security

     ORDS OF 1P

12) Price per share

      139P

13) Date of transaction

      21/05/02

14) Date company informed

      21/05/02

15) Total holding following this notification

      5,000

16) Total percentage holding of issued class following this notification

      0.01%

     IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
                    COMPLETE THE FOLLOWING BOXES

17) Date of grant



18) Period during which or date on which exercisable



19) Total amount paid (if any) for grant of the option



20) Description of shares or debentures involved: class, number.



21) Exercise price (if fixed at time of grant) or indication that price
    is to be fixed at time of exercise



22) Total number of shares or debentures over which options held
    following this notification



23) Any additional information



24) Name of contact and telephone number for queries

      S D EVANS

25) Name and signature of authorised company official responsible for
    making this notification

    Date of Notification  21ST MAY 2002                                


                      DEALINGS BY DIRECTORS


1)  NAME OF COMPANY

    DECHRA PHARMACEUTICALS PLC

2)  NAME OF DIRECTOR

    SIMON EVANS

3)  Please state whether notification indicates that it is in respect of
    holding of the shareholder named in 2 above or in respect of a
    non-beneficial interest or in the case of an individual holder
    if it is a holding of that person's spouse or children under the
    age of 18 or in respect of an non-beneficial interest

     AS ABOVE

4)  Name of the registered holder(s) and, if more than one holder, the
    number of shares held by each of them. (If notified)

     AS ABOVE

5)  Please state whether notification relates to a person(s) connected
    with the Director named in 2 above and identify the connected person(s)

     AS ABOVE

6)  Please state the nature of the transaction. For PEP transactions
    please indicate whether general/single co PEP and if discretionary/non
    discretionary

     PURCHASE OF SHARES

7)  Number of shares/amount of
    stock acquired


       25,000

8)   (0.05%)
    of issued Class



9)  Number of shares/amount
    of stock disposed

      N/A

10)  ( N/A %)
    of issued Class



11) Class of security

     ORDS OF 1P

12) Price per share

      139P

13) Date of transaction

      21/05/02

14) Date company informed

      21/05/02

15) Total holding following this notification

      663,000

16) Total percentage holding of issued class following this notification

      1.32%

     IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
                    COMPLETE THE FOLLOWING BOXES

17) Date of grant



18) Period during which or date on which exercisable



19) Total amount paid (if any) for grant of the option



20) Description of shares or debentures involved: class, number.



21) Exercise price (if fixed at time of grant) or indication that price
    is to be fixed at time of exercise



22) Total number of shares or debentures over which options held
    following this notification



23) Any additional information



24) Name of contact and telephone number for queries

      S D EVANS

25) Name and signature of authorised company official responsible for
    making this notification

    Date of Notification  21ST MAY 2002                                



                      This information is provided by RNS
            The company news service from the London Stock Exchange